Facing Mandatory Fed Price Program, Pharma Goes To Court
The first major lawsuit focused on the Trump administration's so-called "most favored nation" drug pricing efforts hit the courts last week, setting the stage for what could become a bigger fight...To view the full article, register now.
Already a subscriber? Click here to view full article